Lavipharm SA · ATHEX:LAVI

Lavipharm SA shareholders

Lavipharm SA on 6ix: holders from US fund reports. Largest: Emerging Markets Core Equity 2 Portfolio, Dimensional Emerging Markets Core Equity 2 ETF and Emerging Markets Social Core Equity Portfolio. Each with its filing.

Shareholders

HolderSharesValueChangeAs of
Emerging Markets Core Equity 2 Portfolio167KUS$308K+6,439Jul 31, 2026
Dimensional Emerging Markets Core Equity 2 ETF59,961US$110K+49,131Jul 31, 2026
Emerging Markets Social Core Equity Portfolio16,249US$29,864+9,837Jul 31, 2026
Emerging Markets Sustainability Core 1 Portfolio13,888US$25,524No changeJul 31, 2026
Emerging Markets ex China Core Equity Portfolio11,544US$21,216NewJul 31, 2026
Dimensional Emerging Markets ex China Core Equity ETF212US$388No changeJul 31, 2026

Lavipharm SA insider trades